Back to Nick Norwitz

Does the World’s Most Profitable Drug Damage Muscle?

Nick NorwitzFebruary 9, 202613m
AI-Generated Notes

These notes were generated by AI and may contain inaccuracies.

A doctor friend texted: "I'm stopping my statin." Responded with curiosity: "Interesting. What compelled you to make that decision and why now?" He replied, "Haven't you seen this new paper? It scared the sarcomirs out of me." Shared paper analyzing data from 300,000 participants, some followed over a decade. Concludes continuous statin use associated with decline in muscle function and mass over time, with as much as 73% decrease in lean mass compared to non-statin users. Statins are one of the most prescribed drugs on Earth; muscle loss is one of the strongest predictors of disability and mortality.

Continuous statin use significantly associated with accelerated declining grip strength and declining lean mass. Even stronger people declining faster, becoming weaker. Graph initially seemed mistaken due to odd pattern. Five chapters: 1. Study design and main findings. 2. Unexpected results, especially in those who exercise most. 3. Biological mechanisms of statin impairment on muscle. 4. Balanced pros and cons of statins. 5. Protective strategies and supplements for muscle health with age, on or off statins. Check associated Stay Curious Metabolism newsletters below, grounded in data, covering this paper, statins, and other lipid-lowering medications.

Cross-sectional (single time point): In fully adjusted model (adjusting for age, sex, education, smoking, BMI, activity score, diet quality, high blood pressure, diabetes, etc.), statin use associated with lower grip strength and lower appendicular lean mass (arms and legs). Multiple analyses confirmed robustness: inverse association consistent. More statins, lower grip strength, less lean mass.

Sign in to read the full notes

Get access to AI-generated notes, topic timestamps, and more.